Cholesterol drug joins fight against stubborn lung cancer
NCT ID NCT07351565
Summary
This early-stage study is testing if adding a cholesterol-lowering drug called pitavastatin to personalized chemotherapy can help control advanced non-small cell lung cancer that has stopped responding to standard treatments. Doctors will test tumor cells from each patient in a lab to choose the chemotherapy drugs most likely to work for them. The study will enroll about 22 adults to see if this guided combination is safe and can shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.